Metabotropni glutamatni receptor 4 (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Metabotropni glutamatni receptor 4" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

11nih.gov

4^th place

3^rd place

9doi.org

2^nd place

doi.org

dx.doi.org

Makoff A, Lelchuk R, Oxer M, Harrington K, Emson P (Dec 1996). „Molecular characterization and localization of human metabotropic glutamate receptor type 4”. Brain Res Mol Brain Res 37 (1-2): 239–48. DOI:10.1016/0169-328X(95)00321-I. PMID 8738157.
Wu S, Wright RA, Rockey PK, Burgett SG, Arnold JS, Rosteck PR Jr, Johnson BG, Schoepp DD, Belagaje RM (Apr 1998). „Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells”. Brain Res Mol Brain Res 53 (1-2): 88–97. DOI:10.1016/S0169-328X(97)00277-5. PMID 9473604.
Wierońska JM, Stachowicz K, Pałucha-Poniewiera A, Acher F, Brański P, Pilc A (December 2010). „Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems”. Neuropharmacology 59 (7-8): 627–34. DOI:10.1016/j.neuropharm.2010.08.008. PMID 20713068.
Hong SP, Liu KG, Ma G, et al. (July 2011). „Tricyclic thiazolopyrazole derivatives as metabotropic glutamate receptor 4 positive allosteric modulators”. J. Med. Chem. 54 (14): 5070–81. DOI:10.1021/jm200290z. PMID 21688779.
Engers DW, Niswender CM, Weaver CD, et al. (July 2009). „Synthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs)”. J. Med. Chem. 52 (14): 4115–8. DOI:10.1021/jm9005065. PMC 2765192. PMID 19469556.
Williams R, Niswender CM, Luo Q, Le U, Conn PJ, Lindsley CW (2009). „Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-lead”. Bioorg. Med. Chem. Lett. 19 (3): 962–6. DOI:10.1016/j.bmcl.2008.11.104. PMID 19097893.
Niswender CM, Johnson KA, Weaver CD, et al. (2008). „Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4”. Mol. Pharmacol. 74 (5): 1345–58. DOI:10.1124/mol.108.049551. PMC 2574552. PMID 18664603.
Watkins JC, Jane DE (2006). „The glutamate story”. British Journal of Pharmacology 147 (Suppl 1): S100–8. DOI:10.1038/sj.bjp.0706444. PMC 1760733. PMID 16402093.
Beqollari D, Kammermeier PJ (2008). „The mGlu(4) receptor allosteric modulator N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide acts as a direct agonist at mGlu(6) receptors”. European Journal of Pharmacology 589 (1-3): 49–52. DOI:10.1016/j.ejphar.2008.06.054. PMID 18593581.

nih.gov

ncbi.nlm.nih.gov

Makoff A, Lelchuk R, Oxer M, Harrington K, Emson P (Dec 1996). „Molecular characterization and localization of human metabotropic glutamate receptor type 4”. Brain Res Mol Brain Res 37 (1-2): 239–48. DOI:10.1016/0169-328X(95)00321-I. PMID 8738157.
Wu S, Wright RA, Rockey PK, Burgett SG, Arnold JS, Rosteck PR Jr, Johnson BG, Schoepp DD, Belagaje RM (Apr 1998). „Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells”. Brain Res Mol Brain Res 53 (1-2): 88–97. DOI:10.1016/S0169-328X(97)00277-5. PMID 9473604.
„Entrez Gene: GRM4 glutamate receptor, metabotropic 4”.
Wierońska JM, Stachowicz K, Pałucha-Poniewiera A, Acher F, Brański P, Pilc A (December 2010). „Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems”. Neuropharmacology 59 (7-8): 627–34. DOI:10.1016/j.neuropharm.2010.08.008. PMID 20713068.
Hong SP, Liu KG, Ma G, et al. (July 2011). „Tricyclic thiazolopyrazole derivatives as metabotropic glutamate receptor 4 positive allosteric modulators”. J. Med. Chem. 54 (14): 5070–81. DOI:10.1021/jm200290z. PMID 21688779.
Hopkins CR, Niswender CM, Lewis LM, Weaver CD, Lindsley CW. Discovery of a potent, selective and in vivo active mGluR4 positive allosteric modulator. PMID 21433377.
Engers DW, Niswender CM, Weaver CD, et al. (July 2009). „Synthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs)”. J. Med. Chem. 52 (14): 4115–8. DOI:10.1021/jm9005065. PMC 2765192. PMID 19469556.
Williams R, Niswender CM, Luo Q, Le U, Conn PJ, Lindsley CW (2009). „Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-lead”. Bioorg. Med. Chem. Lett. 19 (3): 962–6. DOI:10.1016/j.bmcl.2008.11.104. PMID 19097893.
Niswender CM, Johnson KA, Weaver CD, et al. (2008). „Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4”. Mol. Pharmacol. 74 (5): 1345–58. DOI:10.1124/mol.108.049551. PMC 2574552. PMID 18664603.
Watkins JC, Jane DE (2006). „The glutamate story”. British Journal of Pharmacology 147 (Suppl 1): S100–8. DOI:10.1038/sj.bjp.0706444. PMC 1760733. PMID 16402093.
Beqollari D, Kammermeier PJ (2008). „The mGlu(4) receptor allosteric modulator N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide acts as a direct agonist at mGlu(6) receptors”. European Journal of Pharmacology 589 (1-3): 49–52. DOI:10.1016/j.ejphar.2008.06.054. PMID 18593581.